Publications

Patient (Pt) Preference and Satisfaction with the Subcutaneous Fixed-Dose Combination of Pertuzumab (P) and Trastuzumab (H) in Pts with Her2-Positive Early Breast Cancer (Her2+Ebc): Interim Analysis of the Open-Label, Randomised Cross-Over Phrancesca Study

AuthID
P-00S-AAC

Author(s)

O'Shaughnessy, J

Sousa, SP

Cruz, J

Fallowfield, LJ

Auvinen, P

Pulido, C

Cvetanovic, A

Wilks, S

Ribeiro, L

Burotto, M

Klingbiel, D

Messeri, D

Alexandrou, A

Trask, P

Fredriksson, J

Stamatovic, L

Document Type

Abstract

Year published

2020

Published

in ANNALS OF ONCOLOGY, ISSN: 0923-7534

Volume: 31, Pages: S42-S42 (1)

Conference

Esmo Breast Cancer Virtual Meeting, Date: MAY 23-24, 2020, Location: ELECTR NETWORK, Sponsors: European Soc Med Oncol

Indexing

Wos^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/j.annonc.2020.03.020

Wos: WOS:000538879300072

Source Identifiers

ISSN: 0923-7534

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Patient (Pt) Preference and Satisfaction with the Subcutaneous Fixed-Dose Combination of Pertuzumab (P) and Trastuzumab (H) in Pts with Her2-Positive Early Breast Cancer (Her2+Ebc): Interim Analysis of the Open-Label, Randomised Cross-Over Phrancesca Study

Useful Links

Get Help

Federated Authentication (Click on the image)

Patient (Pt) Preference and Satisfaction with the Subcutaneous Fixed-Dose Combination of Pertuzumab (P) and Trastuzumab (H) in Pts with Her2-Positive Early Breast Cancer (Her2+Ebc): Interim Analysis of the Open-Label, Randomised Cross-Over Phrancesca Study

Useful Links

Get Help